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We previously reported that growth promoter‑induced skeletal muscle hypertrophy co‑ordinately 
upregulated expression of genes associated with an integrated stress response (ISR), as well as 
potential ISR regulators. We therefore used Adeno‑Associated Virus (AAV)‑mediated overexpression 
of these genes, individually or in combination, in mouse skeletal muscle to test whether they 
induced muscle hypertrophy. AAV of each target gene was injected into mouse Tibialis anterior (TA) 
and effects on skeletal muscle growth determined 28 days later. Individually, AAV constructs for 
Arginase‑2 (Arg2) and Activating transcription factor‑5 (Atf5) reduced hindlimb muscle weights and 
upregulated expression of genes associated with an ISR. AAV‑Atf5 also decreased Myosin heavy chain 
(MyHC)‑IIB mRNA, but increased MyHC‑IIA and isocitrate dehydrogenase‑2 (Idh2) mRNA, suggesting 
ATF5 is a novel transcriptional regulator of Idh2. AAV‑Atf5 reduced the size of both TA oxidative and 
glycolytic fibres, without affecting fibre‑type proportions, whereas Atf5 combined with Cebpg (CCAAT 
enhancer binding protein‑gamma) only reduced the size of glycolytic fibres and tended to increase 
the proportion of oxidative fibres. It is likely that persistent Atf5 overexpression maintains activation 
of the ISR, thereby reducing protein synthesis and/or increasing protein degradation and possibly 
apoptosis, resulting in inhibition of muscle growth, with overexpression of Arg2 having a similar 
effect.
We  previously1,2 identified a novel group of genes that were co-ordinately upregulated in pigs administered 
Ractopamine, a beta-adrenergic agonist (BA), and associated with muscle hypertrophy. Inferred Pathway Enrich-
ment analysis highlighted that pathways associated with amino acid biosynthesis and transport were significantly 
upregulated in skeletal muscle of pigs following 3 days of BA administration; a large proportion of these genes 
related to tRNA charging, the urea cycle and serine  biosynthesis2. These genes (summarised in Fig. 1) included, 
but was not limited to, Arginase-2 (ARG2) which catalyses the hydrolysis of arginine to ornithine and urea; 
Asparagine synthetase (ASNS) which catalyses the conversion of L-aspartate and L-glutamine to L-asparagine and 
L-glutamate; and Phosphoglycerate Dehydrogenase (PHGDH) and Phosphoserine aminotransferase (PSAT1), 
which catalyse the first and second steps of the serine biosynthesis pathway. Also upregulated were Sestrin-2 
(SESN2), which negatively regulates mTOR signalling in response to leucine; and Solute Carrier family 3 member 
2 (SLC3A2), which regulates intracellular calcium levels and transports L-type amino acids, such as  leucine1,2. 
We subsequently determined that these targets were associated with an integrated stress response (ISR)3. It is 
unknown what role the proteins encoded by these genes play in regulating the growth of skeletal muscle, par-
ticularly in relationship to growth promoter stimulated muscle hypertrophy.
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These targets are all reported to be transcriptionally upregulated by activating transcription factor-4 (ATF4), 
the main regulator of an ISR, by forming a heterodimer with CCAAT/enhancer binding proteins (C/EBP), par-
ticularly C/EBP-γ (encoded by CEBPG gene)4–7. There was no effect of BA treatment on ATF4 at the mRNA or 
protein level, however ATF5 and CEBPG mRNA were significantly upregulated at day 3 of BA  treatment2. The 
function of ATF5 and C/EBP-γ in terminally differentiated muscle and their role in muscle growth is unknown, 
however this suggests that ATF5 and C/EBP-γ might be potential regulators of the muscle-specific BA-induced 
hypertrophic response observed in pigs.
We previously reported the effect of 28 days Adeno-associated virus (AAV) serotype 1-mediated overexpres-
sion of Pck2 mRNA encoding the mitochondrial isoform of Phosphoenolpyruvate carboxykinase (PEPCK-M) in 
mouse Tibialis anterior (TA) muscle on muscle growth, utilising a contralateral limb  design8. Importantly, AAV 
injection into the TA muscle resulted in equivalent infection of the adjacent Extensor digitorum longus (EDL)8, 
but much lower infection of the adjacent Soleus and Gastrocnemius muscles, meaning both TA and EDL muscles 
could be used for analyses. Here we utilise the same techniques to investigate whether the genes (Arg2, Asns, 
Phgdh, Psat1, Sesn2, Slc3a2) associated with the muscle-specific BA-induced hypertrophic response observed 
in  pigs1,2, could stimulate muscle growth when overexpressed individually in mouse skeletal muscle. We also 
determined whether the ISR associated transcription factors, ATF5 and C/EBP-γ, could stimulate muscle growth 
when overexpressed individually or in combination. To our knowledge, this is the first time that these genes 
(Arg2, Asns, Atf5, Cebpg Phgdh, Psat1, Sesn2, Slc3a2) normally associated with the ISR have been investigated in 
terms of their potential role in muscle growth in vivo.
Figure 1.  Schematic illustrating the role of AAV1-mediated targets associated with energy metabolism, 
protein synthesis and the urea cycle. Schematic highlights (in bold font with bold arrows) the different genes of 
interest (GOI) targeted for AAV1-mediated overexpression in this study and their function. GOI are involved 
in amino acid biosynthesis (Phosphoglycerate Dehydrogenase, PHGDH; Phosphoserine aminotransferase, 
PSAT1; Asparagine synthetase, ASNS), amino acid transport (Solute Carrier family 3 member 2, SLC3A2), 
the urea cycle (Arginase-2, ARG2) and an inhibitor of protein synthesis (Sestrin-2, SESN2). Relative mRNA 
expression was measured for GOIs, amino-acyl tRNA synthetase (Seryl-tRNA synthetase, SARS) and Isocitrate 
dehydrogenase-2 (IDH2) (highlighted in bold font only).
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Results
The contralateral limb design described  previously8 was used to determine the effect of AAV1-mediated overex-
pression of each gene of interest (GOI). Previous  work8 demonstrated that injection of an AAV-Pck2 construct 
into the TA muscle resulted in similar green fluorescence and overexpression of Pck2 in both the TA and EDL 
muscles. Hence, for all the studies described here, the EDL muscle was used for all RNA analyses and the TA 
for muscle histology.
Effect of AAV‑mediated overexpression of genes associated with an integrated stress response 
(ISR) on muscle growth. At the mRNA level, Arginase-2 (AAV-Arg2), Asparagine synthetase (AAV-Asns), 
Phosphoglycerate Dehydrogenase (AAV-Phgdh), Phosphoserine Aminotransferase-1 (AAV-Psat1), Sestrin-2 
(AAV-Sesn2) and Solute Carrier family 3 member 2 (AAV-Slc3a2) were all significantly increased in the EDL 
(P < 0.001; Fig. 2a–f).
Then, we investigated if AAV-mediated overexpression of the individual genes for 28 days induced a change in 
muscle weights compared to their contralateral AAV-Gfp control limb. AAV-Arg2 significantly reduced both TA 
(P = 0.005; Fig. 3a) and EDL (P = 0.01; Fig. 3g) absolute muscle weights, but AAV-Asns, AAV-Phgdh, AAV-Psat1, 
AAV-Sesn2 and AAV-Slc3a2 had no effect on TA muscle weights (Fig. 3b–f). Similarly AAV-Asns, AAV-Psat1 and 
AAV-Sesn2 had no effect on EDL muscle weights (Fig. 3h, j, k), whereas AAV-Phgdh tended to increase (P = 0.06; 
Fig. 3i) and AAV-Slc3a2 significantly reduced EDL muscle weights (P = 0.04; Fig. 3l). There were no effects on 
Gastrocnemius or Soleus muscle weights (Supplementary Figure 1). We subsequently confirmed overexpression 
of the proteins for AAV-Asns, AAV-Phgdh and AAV-Psat1 (Supplementary Figure 2), but we were unable to do 
so for the other genes as we had used up all the TA and EDL muscle samples.
Effect of AAV‑mediated overexpression on endogenous mRNA expression. Next, we investi-
gated if overexpression of the individual target genes altered mRNA expression of the other genes (Asns, Psat1 
and Seryl-tRNA Synthetase (Sars)) previously observed to be upregulated during BA induced pig skeletal muscle 
 hypertrophy1,2. Idh2 mRNA expression was also determined as an example of a gene that was downregulated in 
the pig studies. AAV-mediated overexpression of Arg2 significantly increased Asns, Psat1, Sars, Gadd45a (also 
known as Ddit1) and Ddit3 (also known as C/EBP Homologous Protein (CHOP)) mRNA (all P ≤ 0.01; Fig. 4a) 
but had no effect on Idh2 mRNA. With the exception of their respective target genes (Asns and Psat1), AAV-
mediated overexpression of Asns, Phgdh, Psat1 and Sesn2 had no effect on the expression of the other genes 
(Fig. 4b–e), whilst AAV-Slc3a2 tended to increase Psat1 (P = 0.06) and significantly reduced Sars, Idh2 and Ddit3 
mRNA expression (all P < 0.01; Fig. 4f).
Relative mRNA expression of the Myosin heavy chain (MyHC) isoforms were also measured as markers 
of muscle fibre type, to investigate whether overexpression of any of the genes might induce shifts in muscle 
fibre type. Myh7 encodes slow oxidative MyHC-I, Myh2 encodes fast oxidative MyHC-IIA, Myh1 encodes fast 
oxidative-glycolytic MyHC-IIX and Myh4 encodes fast glycolytic MyHC-IIB, with increased expression of the 
latter often associated with muscle hypertrophy. There were no effects of AAV-Arg2, AAV-Phgdh or AAV-Psat 
on the mRNA expression of any of the MyHC isoforms (Fig. 5a, c, d respectively). However, AAV-Sesn2 signifi-
cantly increased both Myh2 and Myh1 mRNA (both P < 0.001; Fig. 5e), AAV-Asns increased Myh1 mRNA only 
(P = 0.05; Fig. 5b) and AAV-Slc3a2 reduced Myh4 mRNA (P = 0.02; Fig. 5f).
Hence, the AAV1-mediated overexpression of the individual genes were not sufficient to drive the BA-induced 
response observed in  pigs1,2. Therefore, we investigated the effects of Atf5 and/or Cebpg overexpression, as these 
are potential transcriptional regulators for the group of genes.
Figure 2.  Validation of AAV-mediated overexpression of genes associated with an integrated stress response 
(ISR). Adeno-Associated Virus 1 (AAV)-mediated overexpression in the Extensor Digitorum Longus (EDL) 
muscle was validated by real-time quantitative PCR. Relative mRNA expression of target genes, normalised to 
OliGreen as a measure of total cDNA, are shown as follows: (a) Arginase-2 (Arg2), (b) Asparagine synthetase 
(Asns), (c) Phosphoglycerate Dehydrogenase (Phgdh), (d) Phosphoserine Aminotransferase-1 (Psat1), (e) 
Sestrin-2 (Sesn2) and (f) Solute Carrier family 3 member 2 (Slc3a2). Data presented as Means (n = 8, except 
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AAV‑mediated overexpression of activating transcription factor‑5 (Atf5) ± Cebpg on muscle 
growth. As ATF5 forms a heterodimer with CCAAT/enhancer binding protein-γ (C/EBP-γ encoded by 
Cebpg), we utilised the contralateral limb design to study the effect of both AAV-Atf5 and AAV-Cebpg being 
injected separately but also together (AAV-Atf5 + Cebpg) on muscle growth.
QPCR was performed to confirm whether Atf5 and Cebpg were overexpressed at the mRNA level 28 days 
after AAV injections. There tended to be an AAV-Atf5 × AAV-Cebpg interaction (P = 0.08; Fig. 6a) for relative 
Atf5 mRNA expression, but not Cebpg mRNA (Fig. 6b). There was a significant increase in relative Atf5 mRNA 
following AAV-mediated overexpression of Atf5 for 28 days (both AAV-Atf5 and AAV-Atf5 + Cebpg P < 0.001; 
Fig. 6a), but not AAV-Cebpg. There was also a significant increase in Cebpg mRNA following AAV-mediated 
Atf5 overexpression (P = 0.001; Fig. 6b), but not AAV-Cebpg. This demonstrates that transduction with AAV-Atf5 
alone successfully upregulated both Atf5 and Cebpg at the mRNA level, but there were no effects of AAV-Cebpg 
alone. This may mean either that the AAV-Cebpg construct was not functional or that the Cebpg gene expression 
is tightly regulated, but other data suggests that the construct was functional.
There were significant AAV × time interactions following AAV-mediated overexpression of Atf5 alone and 
AAV-Atf5 + Cebpg on both absolute and relative muscle weights for TA (all P < 0.001, Fig. 7a, b and 7j, k respec-
tively) and EDL (P < 0.001, Fig. 7d, e and P < 0.01, Fig. 7m, n). Absolute muscle weights for both TA and EDL 
increased with time (day 28 compared to day 7), whilst muscle weights relative to body weight remained constant. 
There were significant reductions in absolute TA muscle weights 7 days after injection with AAV-Atf5 alone and 
AAV-Atf5 + Cebpg compared to their contralateral control limb TA. Both TA and EDL muscle weights were 
reduced further after 28 days of transduction as is clearly observed in Fig. 7c, l respectively. Indeed, both AAV-
Atf5 and AAV-Atf5 + Cebpg appeared to blunt the growth of both TA and EDL muscles, resulting in a dramatic 
reduction in muscle weights relative to body weight 28 days after AAV injections.
Figure 3.  Effect of AAV-mediated overexpression of genes associated with an integrated stress response 
(ISR) on absolute muscle weights. Adeno-Associated Virus 1 (AAV) particles containing a gene of interest 
(GOI) were injected into mouse Tibialis Anterior (TA) muscle and a GFP control sequence alone (AAV-Gfp) 
into the contralateral TA, then maintained in their home cage for 28 days. GOI included Arginase-2 (AAV-
Arg2), Asparagine synthetase (AAV-Asns), Phosphoglycerate Dehydrogenase (AAV-PHGDH), Phosphoserine 
Aminotransferase-1 (AAV-Psat1), Sestrin-2 (AAV-Sesn2) and Solute Carrier family 3 member 2 (AAV-Slc3a2). 
Data shown as Means (n = 8, except AAV-Sesn2 n = 10) ± SEM for absolute TA (a–f) and Extensor Digitorum 
Longus (EDL; g–l) muscle weights. *(P < 0.05), **(P < 0.01) indicate significantly different from contralateral 
control limb injected with AAV-Gfp.
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There was no effect of AAV-Cebpg on absolute or relative muscle weights and no AAV × time interaction. 
There were significant increases in absolute TA (P < 0.001; Fig. 7f) and EDL (P = 0.004; Fig. 7h) muscle weights, 
as well as relative EDL weights (P = 0.02; Fig. 7i) at 28 days compared to 7 days, but no effect of time for relative 
TA muscle weights (Fig. 7g).
Effect of AAV‑Atf5 ± Cebpg on TA muscle composition. Succinate Dehydrogenase (SDH) staining 
is an indicator of muscle fibres oxidative capacity and mainly identifies type-I and -IIA fibres by staining them 
a darker blue compared to type-IIX and -IIB muscle fibres that are predominantly dependent on glycolytic 
metabolism and therefore remain unstained.
AAV-Atf5 overexpression for 28 days resulted in a significant reduction of minimal feret’s diameter and fibre 
area for both oxidative (dark/intermediate SDH stain) and glycolytic (light) fibres (all P < 0.01; Fig. 8a, b). How-
ever, there was no effect on the proportion of oxidative to glycolytic fibres compared to the contralateral control 
leg muscle (Fig. 8c). This is clearly supported by the representative images in Fig. 8d that show AAV-Atf5 over-
expression resulted in smaller muscle fibres compared to the AAV-Gfp control. The combined AAV-Atf5 + Cebpg 
also resulted in a significant reduction of minimal feret’s diameter and fibre area, but only for glycolytic fibres 
(both P < 0.05; Fig. 8i, j). There was also a tendency for a decrease in the proportion of glycolytic fibres and an 
increase in oxidative fibres (P = 0.09; Fig. 8k). In contrast, AAV-Cebpg had no effect on minimal feret’s diameter 
or fibre area of oxidative or glycolytic muscle fibres (Fig. 8e, f). There was also no effect on the proportion of 
oxidative and glycolytic fibres compared to the contralateral control leg muscle (Fig. 8g). Representative images 
for AAV-Atf5, AAV-Cebpg and AAV-Atf5 + Cebpg compared to the AAV-Gfp control are shown in Fig. 8d, h l 
respectively.
Effect of AAV‑Atf5 ± Cebpg on endogenous mRNA expression. Since ATF5 and C/EBP-γ are 
thought to be transcriptional regulators for the ISR, the expression of Asns, Psat1, Sars, Gadd45a and Ddit3 (all 
ISR genes), as well as Idh2 mRNA were again determined. There was a significant AAV-Atf5 × AAV-Cebpg inter-
action (P = 0.005; Fig. 9e) for relative mRNA expression of Gadd45a, but not the other ISR genes. This was due 
to AAV-Atf5 increasing Gadd45a mRNA expression, but this was reduced (but still higher than control) when 
in combination with AAV-Cebpg, whereas AAV-Cebpg alone had no effect. AAV-Atf5 significantly increased 
Figure 4.  Effect of AAV-mediated overexpression of genes associated with an integrated stress response (ISR) 
on endogenous mRNA expression. Relative mRNA expression for Asparagine Synthetase (Asns), Phosphoserine 
Aminotransferase-1 (Psat1), Seryl-tRNA Synthetase (Sars), Isocitrate dehydrogenase-2 (Idh2), Growth Arrest 
And DNA-Damage-Inducible 45 Alpha (Gadd45a, also known as Ddit1) and DNA Damage Inducible Transcript 
3 (Ddit3, also known as CHOP) were determined in the Extensor Digitorum Longus (EDL) muscle following 
28 days AAV-mediated overexpression of (a) Arg2, (b) Asns, (c) Phgdh, (d) Psat1, (e) Sesn2 and (f) Slc3a2. 
Relative Asns and Psat1 mRNA expression were excluded from AAV-Asns and AAV-Psat1 data respectively 
as these were reported in Fig. 2. All mRNA expression data were normalised to OliGreen, as a measure of 
total cDNA. Data presented as Means (n = 8, except AAV-Sesn2 n = 10) ± SEM. *(P < 0.05) **(P < 0.01) and 
***(P < 0.001) indicate significantly different to contralateral control limb injected with AAV-Gfp.
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Figure 5.  Effect of AAV-mediated overexpression of genes associated with an integrated stress response (ISR) 
on endogenous mRNA expression of myosin heavy chain (MyHC) isoforms. Relative mRNA expression for 
MyHC isoforms were determined in the Extensor Digitorum Longus (EDL) muscle following 28 days AAV-
mediated overexpression of (a) Arg2, (b) Asns, (c) Phgdh, (d) Psat1, (e) Sesn2 and (f) Slc3a2. Myh7 encodes 
MyHC-I, Myh2 encodes MyHC-IIA, Myh1 encodes MyHC-IIX and Myh4 encodes MyHC-IIB. All mRNA 
expression data were normalised to OliGreen, as a measure of total cDNA. Data presented as Means (n = 8, 
except AAV-Sesn2 n = 10) ± SEM. *(P < 0.05) and ***(P < 0.001) indicate significantly different to contralateral 
control limb injected with AAV-Gfp.
Figure 6.  Validation of AAV-mediated overexpression of Atf5 and Cebpg individually and in combination 
(AAV-Atf5 ± Cebpg) at the mRNA level. Relative mRNA expression of (a) Activating transcription factor-5 
(Atf5) and (b) CCAAT/enhancer binding protein gamma (Cebpg) were determined in the Extensor Digitorum 
Longus (EDL) muscle following 28 days AAV-mediated overexpression. mRNA expression data was normalised 
to OliGreen, as a measure of total cDNA. Data presented as Means (n = 8, except n = 24 for AAV-Gfp) ± SEM. 
Ω indicates a trend (P = 0.08) for an AAV-Atf5 × AAV-Cebpg interaction. Different letters indicate significant 
differences (P < 0.05). ***P < 0.001 indicates significant effect of AAV-Atf5 (with or without Cebpg).
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Asns, Psat1, Sars, Idh2 and Ddit3 mRNA expression (all P < 0.01; Fig. 9a–d, f respectively), whereas AAV-Cebpg 
had no effect on any of these genes. This indicates that AAV-mediated Atf5 overexpression alone was capable of 
upregulating the mRNA expression for all these downstream target genes involved in an ISR.
There was no effect of AAV-Atf5 or AAV-Cebpg mediated overexpression on Myh7 mRNA (Fig. 9g). However, 
there was a significant increase in Myh2 (P = 0.006; Fig. 9h) and a reduction in Myh4 (P = 0.002; Fig. 9j) mRNA 
expression following AAV-Atf5 overexpression, but not AAV-Cebpg. There tended to be an AAV-Atf5 × AAV-
Cebpg interaction for Myh1 mRNA (P = 0.06; Fig. 9i), due to a significant increase with the combination of AAV-
Atf5 + Cebpg, but no effects of AAV-Atf5 or AAV-Cebpg separately. This appears to indicate that AAV-Cebpg is 
contributing to this response, indicating the AAV-Cebpg construct was functional, therefore suggesting that the 
lack of change in Cebpg mRNA (Fig. 6b) was due to Cepbg gene expression being tightly regulated. Unfortunately 
we were unable to investigate whether there were effects on protein levels for Atf5 and/or Cebpg, as we had used 
up the TA and EDL muscles in the molecular and histological analyses.
Figure 7.  Effect of 7 and 28 days of AAV-mediated overexpression of Atf5 and Cebpg individually and in 
combination (AAV-Atf5 ± Cebpg) on mouse muscle weights. Absolute and muscle weights relative to body 
weight (BW) for Tibialis anterior (TA; a/b, f/g, j/k) and Extensor digitorum longus (EDL; d/e, h/i, m/n) following 
7 and 28 days of AAV-mediated overexpression of Atf5 (a–e), Cepbg (f–i) or both (AAV-Atf5 + Cebpg, j–n). 
Representative photographs of TA muscle transduced with (c) AAV-Atf5 or (l) AAV-Atf5 + Cebpg and the 
contralateral control TA from the same animal transduced with AAV-Gfp for 28-days. Data presented as Means 
(n = 8) ± SEM. # indicates a significant AAV × time interaction (P < 0.01). Different letters indicate significant 
differences (P < 0.05). *(P < 0.05), **(P < 0.01) and ***(P < 0.001) indicate significant differences in muscle weights 
at day 28 compared to day 7.
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Discussion
The aim of this study was to investigate the effects of AAV1-mediated overexpression of a group of genes in mouse 
skeletal muscle. This group of genes were upregulated in BA treated porcine skeletal  muscle1,2, which included 
downstream targets (Arg2, Asns, Phgdh, Psat1, Sesn2, Slc3a2) and regulators (Atf5, Cebpg) of an ISR. To our 
knowledge, this is the first time these genes have been selectively overexpressed in mouse muscle to determine 
their effects on muscle growth.
We utilised a method described  previously8 to provide localised overexpression (restricted to the hindlimb 
muscles) and compared the effect of overexpression in one leg compared to the contralateral leg injected with 
an AAV-Gfp control. Other groups have used similar approaches in mice and demonstrated that AAV-mediated 
overexpression of Follistatin resulted in muscle hypertrophy, as TA muscle weight was significantly increased 
compared to the contralateral control  TA9. We successfully overexpressed the level of individual genes (Arg2, 
Asns, Phgdh, Psat1, Sesn2, Slc3a2) at the mRNA level following AAV1-mediated transduction for 28 days, con-
firming overexpression at the protein level for Asns, Phgdh and Psat1. Contrary to our original hypothesis that 
Figure 8.  Effect of AAV-mediated overexpression of Atf5 and Cebpg individually and in combination (AAV-
Atf5 ± Cebpg) on muscle fibre size and composition of transduced TA. Succinate Dehydrogenase (SDH) staining 
was performed on 10 µm sections collected from TA muscle transduced with AAV-Atf5 (a–d), AAV-Cebpg 
(e–h) or AAV-Atf5 + Cebpg (i–l) for 28 days and the contralateral TA muscle transduced with AAV-Gfp. Average 
minimal feret’s diameters (a, e, i) and fibre areas (b, f, j) were determined for 15 oxidative (dark/intermediate) 
and 15 glycolytic fibres per field of view. The proportion of dark/intermediate (oxidative) and light (glycolytic) 
fibres (c, g, k) were determined as a percentage of the total number of fibres per field of view. Data presented as 
Means (n = 4–6) ± SEM, where the average of two or three fields of view were taken per sample). Unpaired t-tests 
were performed, *(P < 0.05) and **(P < 0.01) indicate a significant difference between AAV-GOI compared to 
AAV-Gfp control. Representative images were captured at 10 × magnification (d, h, l).
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overexpression might induce hypertrophy, overexpression of the individual downstream ISR targets had no effect 
(AAV-Asns, -Phgdh, -Psat1, -Sesn2, -Slc3a2) or resulted in muscle atrophy (AAV-Arg2) of the transduced TA 
muscle. Arginase has two isoforms: cytosolic ARG1 and mitochondrial ARG2, which catalyse the conversion of 
arginine to ornithine and urea as part of the urea cycle. ARG1 is mainly found in the liver whilst ARG2 is ubiq-
uitously expressed in various  tissues10 and is highly expressed in certain  prostate11 and pancreatic  cancers12,13, 
although lower expression compared to non-malignant tissue has also been  reported14–16. ARG2, but not ARG1, 
was significantly increased following BA-induced muscle hypertrophy in  pigs2, whereas here AAV-Arg2 overex-
pression resulted in a significant reduction in mouse TA and EDL muscle weights. Relative mRNA expression 
of Asns, Psat1, Sars, Gadd45a and Ddit3 were all significantly increased in the EDL; which might indicate the 
activation of an ISR, possibly due to increased arginine hydrolysis, resulting in nutrient deprivation. This poten-
tially demonstrates that by selectively overexpressing Arg2 alone, a shift in protein synthesis is induced through 
the upregulation of other enzymes involved in amino acid synthesis (e.g. ASNS and PSAT1 for asparagine and 
serine biosynthesis respectively) and aminoacyl-tRNA-synthetases in protein translation (e.g. SARS). However, 
since Gadd45a and Ddit3 are known to be activated by endoplasmic reticulum (ER) stress and to subsequently 
promote apoptosis, the increases in their expression may be partly responsible for the muscle  atrophy17–19.
We reported previously that PEPCK-M overexpression also resulted in slight muscle  atrophy8. PEPCK-M is 
reported to be upregulated in certain forms of cancer leading to reprogramming of energy metabolism to aid 
tumour cell growth and  progression20,21. Similarly, ASNS, PHGDH, PSAT1 and SLC3A2 are all highly expressed 
in different forms of  cancer22,23, however little is known about their role in skeletal muscle growth and hyper-
trophy. There was no effect on TA muscle weight following AAV-Slc3a2 overexpression, whereas EDL muscle 
weight was significantly reduced. The lack of response may be a result of increased variability in the larger TA 
(~ 45 mg) versus smaller EDL (~ 10 mg) muscle or slight differences in fibre-type composition between the dif-
ferent hindlimb muscles; however this would need further investigation with increased replicates to clarify. In 
contrast, SESN2 expression is reported to be largely suppressed in many cancers, despite the high level of reactive 
oxygen species, but there are also reports of increased SESN2 expression in some  cancers24. SESN2 is an inhibitor 
of mTOR and therefore protein synthesis, so it was surprising that AAV-Sesn2 had no effect on muscle weight, 
particularly as there were significant increases in both Myh2 and Myh1 mRNA expression (encode MyHC-IIA 
and –IIX respectively). It is possible that AAV-Sesn2 overexpression (or other AAV targets) for longer than 
Figure 9.  Effect of AAV-mediated overexpression of Atf5 and Cebpg individually and in combination (AAV-
Atf5 ± Cebpg) on endogenous mRNA expression. Relative mRNA expression for (a) Asparagine synthetase 
(Asns), (b) Phosphoserine Aminotransferase-1 (Psat1), (c) Seryl-tRNA Synthetase (Sars), (d) Isocitrate 
dehydrogenase-2 (Idh2), (e) Growth Arrest and DNA-Damage-Inducible 45 Alpha (Gadd45a, also known 
as Ddit1), (f) DNA Damage Inducible Transcript 3 (Ddit3, also known as CHOP), and (g–j) Myosin heavy 
chain (MyHC) isoforms were determined in the Extensor Digitorum Longus (EDL) muscle following 28 days 
AAV-mediated overexpression. (g) Myh7 encodes slow oxidative MyHC-I, (h) Myh2 encodes fast oxidative 
MyHC-IIA, (i) Myh1 encodes fast oxidative-glycolytic MyHC-IIX and (j) Myh4 encodes fast glycolytic MyHC-
IIB. All mRNA expression data was normalised to OliGreen, as a measure of total cDNA. Data presented as 
Means (n = 8, except n = 24 for AAV-Gfp) ± SEM. φ indicates a significant AAV-Atf5 × AAV-Cebpg interaction 
(P = 0.005), and Ω indicates a trend for an interaction (P = 0.06); different letters indicate statistical significance 
(P < 0.05). **P < 0.01, ***P < 0.001 indicates significant effect of AAV-Atf5.
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28 days might have induced a muscle phenotype, however we show here and  previously8 that 28 days is adequate 
to detect changes in TA and EDL muscle weights.
The BA-induced hypertrophic response observed in porcine skeletal muscle was associated with a clear 
coordinated upregulation of a group of  genes1,2. Although AAV-Arg2 overexpression was capable of inducing 
a selection of these genes at the mRNA level (Asns, Psat1, Sars) it was also associated with muscle atrophy and 
the upregulation of Gadd45a and Ddit3 mRNA, both of which are associated with ER stress and  apoptosis17–19. 
We hypothesised that it might be necessary to overexpress a regulator for this group of genes in order to recre-
ate the synchronous coordinated response and therefore induce muscle hypertrophy. Using HepG2 cells, ATF5 
overexpression has been reported to transactivate ASNS, a marker of ER  stress25, and co-transfection with Cebpg 
induced Pgc-1α promoter  activity26. Atf5 and Cebpg demonstrated the same response profile as the group of tar-
get  genes2 and therefore offer plausible candidates that might regulate this hypertrophic response. However, we 
demonstrate for the first time that chronic overexpression of Atf5 (alone or combined with Cebpg) for 28 days in 
mouse TA muscle reduced TA muscle weights, as well as average fibre diameter and fibre area. Relative isocitrate 
dehydrogenase-2 (Idh2) mRNA expression was significantly upregulated following AAV-Atf5 overexpression, 
therefore we also report the novel observation of ATF5 as a potential transcriptional regulator of Idh2. Idh2, 
a marker of oxidative metabolism, was downregulated in porcine skeletal muscle treated with  BA1, therefore 
supporting the observed fibre-type shift to a more fast-twitch, glycolytic phenotype indicated by an increase in 
Myh4 (encodes MyHC-IIB) mRNA, as well as a decrease in Myh1 (MyHC-IIX) and Myh2 (MyHC-IIA)1. The 
reverse was observed in this study, where chronic overexpression of either Atf5 alone or Atf5 + Cebpg blocked the 
normal muscle growth and maturation. AAV-Atf5 reduced muscle fibre size (diameter and area) of oxidative and 
glycolytic fibres, whereas AAV-Atf5 + Cebpg only reduced the size of glycolytic fibres. This inhibition of muscle 
growth was associated with a significant increase in Myh2 and Idh2 mRNA and a decrease in Myh4 mRNA fol-
lowing AAV-mediated overexpression of Atf5 alone and in combination with Cebpg (AAV-Atf5 + Cebpg), therefore 
indicating a shift in oxidative capacity. AAV-Atf5 had no effect on the proportion of oxidative versus glycolytic 
fibres, however AAV-Atf5 + Cebpg tended to increase the proportion of oxidative fibres in the transduced TA 
muscle. AAV-Atf5 + Cebpg appeared to have a different phenotypic effect compared to AAV-Atf5 alone, therefore 
suggesting that AAV-Cebpg was functional, despite no changes in Cebpg mRNA expression and AAV-Cebpg 
alone having no effect. It would be useful to confirm overexpression of both Atf5 and Cebpg at the protein level, 
particularly at an earlier time point, but we were unable to do so due to the EDL and TA muscles being used up in 
the molecular (gene expression) and histology (muscle fibre type and size) analyses respectively. The role of ATF5 
in muscle growth is unknown, however this highlights that ATF5 might be the key regulator for this response. It 
is possible that ATF5 upregulation mimics a state of nutrient deprivation, therefore inducing an integrated stress 
or similar stress response. Under normal conditions, once nutrient levels have returned to normal, the ISR would 
be terminated and therefore Atf5 downregulated. In our study, Atf5 levels were maintained at a high level for 
28 days leading to chronic activation of the ISR, as indicated by increased Asns, Psat1, Sars, Gadd45a and Ddit3 
mRNA, and as a result potentially suppresses protein synthesis or increases protein degradation and apoptotic 
processes, therefore leading to inhibition of muscle growth. As BA treatment was administered to pigs  daily1,2, 
this possibly resulted in a pulsatile activation of the ISR. A similar induction of Atf5 overexpression might be 
necessary in order to induce muscle hypertrophy, therefore future work should investigate the administration 
of inducible short-term pulses of Atf5 overexpression in mouse muscle rather than the chronic overexpression 
studied here. It should be noted that the increases in mRNA expression observed here in AAV infected mice 
were substantially greater than those observed previously in BA treated pigs, with the fold changes observed in 
mice being around 10–80 times more than in pigs, with a range between 1.8-fold (for Arg2) and 150 fold (for 
Sens2) greater increases in AAV mice. Hence, better control of both the level of overexpression and the time of 
overexpression (acute vs chronic) may be necessary. Alternatively, it could simply be that pigs and mice respond 
differently and therefore mice are not a good model for pigs.
Conclusion
We clearly demonstrate for the first time that AAV-mediated overexpression of either Arg2 or Atf5 in mouse TA 
muscle result in muscle atrophy associated with a co-ordinated induction of the mRNA expression of ISR genes 
(Asns, Psat1, Sars, Gadd45a and Ddit3) in skeletal muscle. We also report that AAV-Atf5 increased Idh2 mRNA 
expression in muscle, indicating that ATF5 may be a transcription factor that binds to the Idh2 gene promoter. 
We hypothesise that the chronic overexpression of AAV-Atf5 induces muscle atrophy because it prevents ter-
mination of the ISR (or similar stress response), leading to the induction of markers of ER stress and apoptosis 
(Gadd45a and Ddit3). Future work should investigate the effects of short-term inducible Atf5 overexpression for 
possible induction of muscle hypertrophy.
Methods
Animals. Male C57BL6/J mice (aged 5–6-weeks; Charles River UK Ltd.) were kept at a controlled tempera-
ture (21 ± 1 °C) and held on 12 h light: 12 h dark photoperiod (lights off at 19:00) with ad libitum access to rodent 
chow (Teklad 2018, Envigo, UK) and filtered water. Mice were group housed (n = 2–4 per cage) and health status 
monitored throughout. All animal procedures were approved by The University of Nottingham Ethical Review 
Committee and conducted in accordance with the UK Animals (Scientific Procedures) Act of 1986 (Project 
License PPL PFBB3B51F), meaning that they are in compliance with ARRIVE guidelines.
Adeno‑associated virus (AAV). The following vectors were designed using the VectorBuilder platform 
(https:// en. vecto rbuil der. com/; previously Cyagen Biosciences, now VectorBuilder Inc) and the specified mouse 
mRNA sequence accession numbers: pAAV-CMV-Arg2-T2A- EmGfp (abbreviated to AAV-Arg2; Accession 
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number NM_009705.3), pAAV-CMV-Asns-T2A- EmGfp (AAV-Asns; XM_006505093.2), pAAV-CMV-Atf5-
T2A- EmGfp (AAV-Atf5; NM_030693.2), pAAV-CMV-Cebpg-T2A- EmGfp (AAV-Cebpg; XM_006539500.2), 
pAAV-CMV-Phgdh-T2A- EmGfp (AAV-PHGDH; NM_016966.3), pAAV-CMV-Psat1-T2A- EmGfp (AAV-
Psat1; NM_177420.2), pAAV-CMV-Sesn2-T2A- EmGfp (AAV-Sesn2; NM_144907.1), pAAV-CMV-Slc3a2-T2A- 
EmGfp (AAV-Slc3a2; NM_001161413.1) and pAAV-CMV-EmGfp (AAV-Gfp). The stop codon for each gene of 
interest (GOI) was removed and a viral T2A sequence included to ensure co-translational cleavage of the target 
protein from the green fluorescent protein (GFP)27. Hence both proteins are expected to be expressed in equi-
molar concentrations and the GFP acts as a marker of target protein  expression28.
Intramuscular AAV injections. As previously  described8, mice were administered with single 20 µl injec-
tions containing approximately 1.2 ×  1010 viral genome copies (GC) into both the left and right Tibialis anterior 
(TA) muscles while under recoverable anaesthesia (1.5% Isoflurane). We again used a contralateral leg design 
such that each AAV-GOI (target gene linked with GFP tag) was injected into the left TA and equivalent number 
of AAV1 particles containing GFP (AAV-Gfp) injected into the right TA as the control. Mice were then recovered 
from anaesthesia and maintained in their home cages for 28 days.
Single and combined injections were performed for AAV-Atf5 and AAV-Cebpg, such that mice were injected 
with 3.1 ×  109 viral GC (in 20 µl) of AAV-Atf5, AAV-Cebpg or AAV-Atf5 + AAV-Cebpg (3.1 ×  109 GC of each AAV 
in a total volume of 20 µl) into the left TA and equivalent GC number of AAV-Gfp into the right TA. Mice were 
then maintained in their home cages for 7 or 28 days.
Termination. Mice were euthanized by cervical dislocation and the TA, Extensor digitorum longus (EDL), 
Soleus and Gastrocnemius hindlimb muscles dissected, weighed and snap frozen on dry-ice (n = 8 animals per 
GOI, except AAV-Sesn2 n = 10). For mice injected with AAV-Atf5 and/or AAV-Cebpg, TA and EDL muscles 
were collected 7 and 28 days after AAV injections (n = 8 animals per AAV per time-point). TA muscles were 
either transversely cut (AAV-Asns, -Phgdh, -Psat) and the distal half embedded with OCT or whole muscles 
were embedded in OCT (all other AAV targets), then OCT embedded muscles were frozen using dry ice cooled 
isopentane for muscle sectioning. The proximal half of the TA and whole EDL muscles were snap frozen on dry 
ice. All samples were stored at − 80 °C prior to analyses.
Gene expression analyses. Gene expression was determined on whole EDL. Total RNA was extracted 
and quantitative RT-PCR carried out using the SYBR green method as previously  described29. Relative mRNA 
expression was normalised to Oligreen as a measure of total cDNA. QPCR primers were designed using the Mus 
musculus genome and can be found in Table 1. QPCR primers for the mRNA transcripts of adult myosin heavy 
chain isoforms (Myh1, Myh2, Myh4, Myh7), Asns, Atf5, Cebpg, Phgdh, Psat1, Gadd45a (also known as Ddit1) and 
Ddit3 (also known as C/EBP Homologous Protein (CHOP)) are reported elsewhere 29,30.
Muscle sectioning and succinate dehydrogenase (SDH) staining. TA muscle was mounted with 
OCT at below − 20  °C and then sectioned using a Cryostat (Bright instrument: OTF5000-001/D/MR, Serial 
Number: 065014/5668). Sections (10 µm) were taken after sectioning approximately 100 µm from the transverse 
cut into the TA muscle. Six sections were collected per slide (Superfrost Plus, Thermo Scientific) and four slides 
were collected per muscle. Slides were stored at − 20 °C until histochemical analysis was performed. SDH stain-
ing was carried out by submerging slides in a SDH incubation solution (saturated disodium succinate, 50 mM 
Tris–HCl (pH 7.4), 1 mg/ml Nitro blue tetrazolium, 0.02 mM  MgCl2) and incubated at 37 °C for 1 h. Slides were 
washed in distilled water for 1 min, followed by 50% ethanol, 70% ethanol and 100% ethanol. Slides were then 
mounted with Omnimount mounting medium (HS-110, National diagnostics) and left to air-dry in the fume 
hood overnight. Two or three representative fields of view were captured per muscle section at 10 × magnifica-
tion and the average minimal feret’s diameters (µm) and fibre areas (µm2) determined for 15 randomly selected 
‘dark/intermediate (oxidative)’ and ‘light (glycolytic)’ muscle fibres per field of view. Proportions were deter-
mined (as a %) relative to the total number of muscle fibres per field of view.
Statistical analyses. All data are presented as means ± standard error of the mean (SEM). All statistical 
analyses were performed in Genstat  (19th edition), with P < 0.05 considered statistically significant. Paired Stu-
dent’s t-tests were used to compare muscle weight and gene expression data from experimental (TA injected 
with AAV-GOI) and contralateral control (TA injected with AAV-Gfp) legs of the same animals. For the 
AAV-Atf5 ± Cebpg study, a general two-way (AAV × time for muscle weights) or unbalanced two-way (AAV-
Atf5 × AAV-Cebpg for gene expression) ANOVA was used, blocking for ‘animal’, followed by post-hoc Bonfer-
roni multiple comparison tests as appropriate (P < 0.05 for ANOVA). Minimal feret’s diameters, fibre areas and 
fibre type proportions were analysed by unpaired t-tests.
Table 1.  Forward and reverse QPCR primers for the murine genes.
Gene Forward (5′ → 3′) Reverse (5′ → 3′)
Arg2 ACC ACA GCC TGG CAA TAG GT TCA ACC CAG ATG ACA CAG AGA TCT 
Sars TTT GAG AAG ATT GAG CAG TTT GTG TA CGG TGG CGA TCA TCT CAT C
Slc3a2 GAG GAC AGG CTT TTG ATT GCA TCG CTG GTG GAT TCA AGT ATGT 
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Data availability
The datasets generated and/or analysed during the current study are available from the corresponding author 
on reasonable request.
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